Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$466.6K
130K shares
What this filing means
BORGESON BLAKE plans to sell 130K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $466.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001959173-26-006610
Director
Since Apr 2021
130K
Shares to sell
$466.6K
Approx. market value
30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/19/2017
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2017 | Founders Shares Compensation | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
30K
Market value
$97.5K
8/4/2026
—Completed
Units to sell
40K
Market value
$158.5K
7/7/2026
—Completed
Units to sell
30K
Market value
$110.4K
6/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$100.2K
9/1/2026
Total
Units
130K
Value
$466.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/4/2026 | 30K | $97.5K | — | Completed |
7/7/2026 | 40K | $158.5K | — | Completed |
6/2/2026 | 30K | $110.4K | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 30K | $100.2K | NASDAQ | Planned |
| Total | 130K | $466.6K | ||